Your browser doesn't support javascript.
loading
Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.
Rashdan, Hannah; Zhang, Shijia; Wan, Guihong; Nguyen, Nga; Roster, Katie; Rajeh, Ahmad; Tang, Kimberly; Chen, Wenxin; Moseley, Cameron; Chen, Steven; LeBoeuf, Nicole; Semenov, Yevgeniy R.
Affiliation
  • Rashdan H; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Zhang S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Wan G; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Nguyen N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Roster K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Chen W; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Moseley C; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Chen S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • LeBoeuf N; Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 90(5): 1080-1083, 2024 May.
Article de En | MEDLINE | ID: mdl-38290617
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs / Antinéoplasiques Type d'étude: Etiology_studies / Observational_studies Limites: Humans Langue: En Journal: J Am Acad Dermatol / J. Am. Acad. Dermatol / Journal of the American Academy of dermatology Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs / Antinéoplasiques Type d'étude: Etiology_studies / Observational_studies Limites: Humans Langue: En Journal: J Am Acad Dermatol / J. Am. Acad. Dermatol / Journal of the American Academy of dermatology Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique